Cencora to acquire American Oncology Network in $2.4 billion deal
+1 new source since this summary was written
Cencora announced a definitive agreement to buy American Oncology Network for an enterprise value of $2.4 billion, consisting of $2.3 billion payable at closing and up to $100 million in contingent value rights. The transaction will expand Cencora’s physician‑led oncology management services into twelve additional states and is expected to be accretive to adjusted diluted EPS in the second year after closing. Cencora also raised its fiscal‑2026 adjusted EPS guidance to at least $17.90 per share.
Why it matters
The company says the acquisition will boost adjusted EPS in year two, supporting its growth outlook. It also lifted its FY‑2026 EPS guidance to $17.90, the high end of the prior range. The announcement sent Cencora’s shares down 4.84% to $325.50, indicating immediate market reaction.
Key facts
- 1Enterprise value of the transaction is $2.4 billion. srnnews.com
- 2$2.3 billion will be paid at closing. tradingview.com
- 3Up to $100 million in contingent value rights are included. investing.com
- 4Cencora expects the deal to be accretive to adjusted diluted EPS in the second year post‑closing. stocktitan.net
- 5Adjusted diluted EPS guidance for fiscal 2026 was raised to at least $17.90 per share. investing.com
- 6Cencora currently holds approximately 4% of AON’s equity. investing.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.